•  
  •  
  •  
  •  

2026-07-20 01:23:44

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Keywords Selected:  FermentaBiotech

Stock Report

  • Fermenta Biotech Ltd receives FSSAI nod for its product Vitamin D3 (Cholecalciferol) - Plant Source
  • Fermenta ranked among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
  • Fermenta Board approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
  • Fermenta Biotech Limited Certified as a Great Place to Work®
  • Fermenta Board approves sale of Environmental Solutions Business to Wholly Owned Subsidiary
  • Fermenta Granted Process Patent for Plant-Based Vitamin D3
  • Fermenta announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
  • Fermenta Signs Strategic MoU with NIFTEM-T to Strengthen India's Food Fortification Landscape
  • Fermenta enters its 75th Year, Celebrating a Legacy Built on Trust
  • Fermenta's Plant-based Vitamin D3 is 'Innovation of the Year'
  • Fermenta Biotech Ltd's API manufacturing facility receives certificate of EU GMP compliance
  • Fermenta Biotech Limited receives EIR from USFDA for Dahej manufacturing facility
  • Fermenta Biotech Ltd executes sale deed for land sale
  • Fermenta Biotech Ltd posts Rs. 1.83 crore PAT in Q1FY24
  • Fermenta Biotech Limited recommends final dividend of Rs. 1.25
  • Fermenta Biotech Ltd posts consolidated loss of Rs. 3.74 crore in Q4FY23
  • Fermenta Biotech Ltd sells property of Rs. 11.33 crores
  • Fermenta Biotech Ltd sinks to Q3FY23 consolidated loss of Rs. 37.39 crores
  • Fermenta Biotech Ltd executes sale deed to sell premises at Thane One Building
  • Fermenta Biotech Limited executes sale deed for property sale
  • Fermenta Biotech Ltd Q1 FY2023 consolidated loss at Rs. 2.30 crore
  • Fermenta Biotech extends validity period of binding term sheet for real estate development
  • Fermenta Biotech Q3FY22 consolidated loss at Rs. 8.04 crores
  • Fermenta Biotech Ltd and Mextech Property Developers LLP sign Binding Term Sheet for Real Estate Development

Latest Post

  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025